Daxor Corporation - Asset Resilience Ratio
Daxor Corporation (DXR) has an Asset Resilience Ratio of 65.10% as of December 2011. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2011)
This chart shows how Daxor Corporation's Asset Resilience Ratio has changed over time. Check Daxor Corporation PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Daxor Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Daxor Corporation (DXR) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $55.80 Million | 65.1% |
| Total Liquid Assets | $55.80 Million | 65.10% |
Asset Resilience Insights
- Very High Liquidity: Daxor Corporation maintains exceptional liquid asset reserves at 65.10% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Daxor Corporation Industry Peers by Asset Resilience Ratio
Compare Daxor Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.46% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Annual Asset Resilience Ratio for Daxor Corporation (2000–2011)
The table below shows the annual Asset Resilience Ratio data for Daxor Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2011-12-31 | 65.10% | $55.80 Million | $85.72 Million | +6.02pp |
| 2010-12-31 | 59.08% | $53.88 Million | $91.20 Million | -11.77pp |
| 2009-12-31 | 70.85% | $53.27 Million | $75.19 Million | -18.10pp |
| 2008-12-31 | 88.96% | $68.34 Million | $76.82 Million | +15.91pp |
| 2007-12-31 | 73.05% | $74.92 Million | $102.56 Million | -12.63pp |
| 2006-12-31 | 85.67% | $66.97 Million | $78.17 Million | -10.43pp |
| 2005-12-31 | 96.11% | $57.25 Million | $59.57 Million | -1.89pp |
| 2004-12-31 | 97.99% | $54.81 Million | $55.93 Million | -0.14pp |
| 2003-12-31 | 98.14% | $47.40 Million | $48.30 Million | +0.54pp |
| 2002-12-31 | 97.59% | $40.57 Million | $41.57 Million | +0.51pp |
| 2001-12-31 | 97.09% | $42.27 Million | $43.54 Million | -1.19pp |
| 2000-12-31 | 98.28% | $48.72 Million | $49.58 Million | -- |
About Daxor Corporation
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corpo… Read more